Related Experiment Videos
Pharmaceutical care versus traditional drug treatment. Is there a difference?
C D Hepler1, T J Grainger-Rousseau
1Department of Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, USA.
Drugs
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preventing drug-related morbidity--determining valid indicators.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2002
Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Improving drug therapy for patients with asthma--part 1: Patient outcomes.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Regulating for outcomes as a systems response to the problem of drug-related morbidity.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
[Quality assurance of drug therapy for patients with asthma. Health economic analysis].
Ugeskrift for laeger·2000
Evaluation of patient's Health-Related Quality of Life using a modified and shortened version of the Living With Asthma Questionnaire (ms-LWAQ) and the medical outcomes study, Short-Form 36 (SF-36).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·1999
Baxdrostat: First Approval.
Drugs·2026
Andamertinib: First Approval.
Drugs·2026
Cefepime/Zidebactam: First Approval.
Drugs·2026
Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.
Pharmaceuticals (Basel, Switzerland)·2026
Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.
Pharmaceuticals (Basel, Switzerland)·2026
Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.
International journal of molecular sciences·2026
From syndrome to precision therapy: current and emerging therapeutic options for selected pediatric focal epilepsies.
Expert opinion on pharmacotherapy·2026